Escitalopram Treatment of Major Depression in Patients With Temporal Lobe Epilepsy
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This is a research study evaluating the use of escitalopram (Lexapro®) for the treatment of
major depression in subjects with temporal lobe epilepsy. The purpose of the study is to
measure the severity and change in depressive and anxiety symptoms after 10 weeks of study
treatment with escitalopram or placebo as measured by certain rating scales and
questionnaires. In addition, the study will measure the frequency of seizures using a patient
diary during the study. Finally, the study will assess the change in the quality of life
using rating scales.